Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 4
Real-world experience in treatment of patients with non-small-cell lung cancer with BRAF or cMET exon 14 skipping mutations
Urška Janžič, Walid Shalata, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopović, Giannis Mountzios, Adam Płużański, António Araújo, Andriani Charpidou, Abed Agbarya
Izvirni znanstveni članek
Oznake: nedrobnocelični pljučni rak;mutacija BRAF V600;podatki iz resničnega življenja;tarčna terapija;zdravljenje prvega reda;non-small-cell lung cancer;BRAF V600 mutation;cMET exon 14 skipping mutation;real-world data;targeted therapy;first-line therapy;
BRAF and cMET exon 14 skipping are rare mutations of NSCLC. The treatment sequence in these cases for the first and second line is not clear. An international registry was created for patients with advanced NSCLC harboring BRAF or cMET exon 14 skipping mutations, diagnosed from January 2017 to June ...
Leto: 2023 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma
Agnes Bilecz, Paul Stockhammer, Dirk Theegarten, Izidor Kern, Marko Jakopović, Miroslav Samaržija, Thomas Klikovits, Mir Alireza Hoda, Balazs Dome, Felicitas Oberndorfer
Izvirni znanstveni članek
Oznake: epiteloidni maligni plevralni mezoteliom;histološki podtipi;epithelioid malignant pleural mesothelioma;histological subtypes;
Malignant pleural mesothelioma (MPM) is a rare malignancy with a dismal prognosis. While the epithelioid type is associated with a more favourable outcome, additional factors are needed to further stratify prognosis and to identify patients who can benefit from multimodal treatment. As epithelioid M ...
Leto: 2020 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Access to novel drugs for non-small cell lung cancer in Central and Southeastern Europe
Tanja Čufer, Tudor Ciuleanu, Peter Berzinec, Gabriela Galffy, Marko Jakopović, Jacek Jassem, Dragana Jovanovic, Zhasmina MIhaylova, Gyula Ostoros, Christiane Thallinger, Milada Zemanova, Christoph Zielinski
Izvirni znanstveni članek
Oznake: nedrobnocelični rak pljuč;zdravljenje;nova zdravila;Srednja Evropa;Jugovzhodna Evropa;non-small cell lung cancer;treatment;novel drugs;Central Europe;Southeastern Europe;
Background. Treatment of non-small cell lung cancer (NSCLC) improved substantially in the last decades. Novel targeted and immune-oncologic drugs were introduced into routine treatment. Despite accelerated development and subsequent drug registrations by the European Medicinal Agency (EMA), novel dr ...
Leto: 2020 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer
Lidija Ljubicic, Urška Janžič, Mojca Unk, Ana Sophie Terglav, Katja Mohorčič, Fran Seiwerth, Lela Bitar, Sonja Badovinac, Sanja Pleština, Marta Koršić, Suzana Kukulj, Miroslav Samaržija, Marko Jakopović
Izvirni znanstveni članek
Oznake: onkologija;pljučne bolezni;antiangiogena terapija;docetaksel;nintedanib;
Leto: 2023 Vir: Onkološki inštitut Ljubljana (OI)
Št. zadetkov: 4
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: